Invention Grant
US09523688B2 Diagnosis method and treatment for cancer using liv21 proteins and E2F1/E2F4 biomarkers
有权
使用liv21蛋白和E2F1 / E2F4生物标志物的诊断方法和治疗癌症
- Patent Title: Diagnosis method and treatment for cancer using liv21 proteins and E2F1/E2F4 biomarkers
- Patent Title (中): 使用liv21蛋白和E2F1 / E2F4生物标志物的诊断方法和治疗癌症
-
Application No.: US11908103Application Date: 2006-03-07
-
Publication No.: US09523688B2Publication Date: 2016-12-20
- Inventor: Laurence Faure
- Applicant: Laurence Faure
- Agency: Young & Thompson
- Priority: FR0502257 20050307; FR0502258 20050307
- International Application: PCT/FR2006/000510 WO 20060307
- International Announcement: WO2006/095086 WO 20060914
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574 ; C07K14/47 ; C07K16/30 ; G01N33/50 ; G01N33/68 ; A61K38/00
Abstract:
The invention concerns a novel diagnostic and/or prognostic test for cancer. More particularly, the invention concerns the human LIV21 protein, its use as cancer diagnostic and prognostic markers. The invention also concerns methods for treating cancers and neurodegenerative diseases as well as compositions therefor.
Public/Granted literature
- US20100285971A1 Traceability of Cellular Cycle Anomalies Targeting Oncology and Neurodegeneration Public/Granted day:2010-11-11
Information query
IPC分类:
